Bridging past and future: the evolution of genetic diagnosis in FSHD and the role of emerging technologies in a globalized framework
- 15 April 2026
- journal article
- review article
- Published by Elsevier in Neuromuscular Disorders
- Vol. 63, 106434
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Health
This publication has 128 references indexed in Scilit:
- Clinical application of single‐molecule optical mapping to a multigeneration FSHD1 pedigreeMolecular Genetics & Genomic Medicine, 2019
- Inflammatory facioscapulohumeral muscular dystrophy type 2 in 18p deletion syndromeAmerican Journal of Medical Genetics Part A, 2018
- Molecular combing reveals complex 4q35 rearrangements in Facioscapulohumeral dystrophyHuman Mutation, 2017
- Hemizygosity forSMCHD1in Facioscapulohumeral Muscular Dystrophy Type 2: Consequences for 18p Deletion SyndromeHuman Mutation, 2015
- Identification of Variants in the 4q35 GeneFAT1in Patients with a Facioscapulohumeral Dystrophy-Like PhenotypeHuman Mutation, 2015
- Molecular combing reveals allelic combinations in facioscapulohumeral dystrophyAnnals of Neurology, 2011
- Common epigenetic changes of D4Z4 in contraction-dependent and contraction-independent FSHDHuman Mutation, 2009
- Somatic mosaicism in FSHD often goes undetectedAnnals of Neurology, 2004
- Facioscapulohumeral muscular dystrophy with EcoRI/BlnI fragment size of more than 32 kbMuscle & Nerve, 2002
- Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number ofKpnI repeats at the 4q35 locus and clinical phenotypeAnnals of Neurology, 1999